OneMedNet
VS
Scribe Therapeutics

Biotech comparison — funding, valuation, and investors, sourced from Value Add Pulse coverage.

O
OneMedNet

OneMedNet provides a platform for curating and exchanging real-world medical imaging and clinical data from healthcare provider networks to power life sciences, AI development, and academic research.

2 Pulse stories
ST
Scribe Therapeutics

Clinical-stage biotech developing CRISPR-based gene-editing therapeutics using its proprietary CasX enzyme platform.

5 Pulse stories
Total RaisedNot disclosed
Last ValuationNot disclosed
Biotech
Sector
Biotech
2006
Founded
2018
Eden Prairie, Minnesota
HQ
Alameda, California
Public (ONMD)
Status
Public (SCTX)
OneMedNet investors
No investors on record.
Scribe Therapeutics investors
No investors on record.

Data from Value Add Pulse coverage and company research — see the full threads for OneMedNet and Scribe Therapeutics.